Chief Financial Officer

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Orchestra BioMed reports Q3 EPS (40c), consensus (43c)

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Sr. Director Field Clinical

Orchestra BioMed is a biomedical innovation company focused on accelerating high-impact technologies to patients through strategic collaborations. The Sr. Director/Director will lead the Field Clinical Specialists in driving the Interventional Therapies Clinical Trial, managing critical field activities and ensuring successful execution of clinical trials.

Sign up with Google

Sign in with Google